NCT00453583

Brief Summary

This is a non-interventional retrospective data collection study from children aged from 2 to 12 years old diagnosed with an allergy and who received a treatment consisting of an H1-antihistamine. The period of last taken medication will be observed to evaluate the global satisfaction of the parents and physician for this last treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,581

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2007

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2007

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

March 28, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 29, 2007

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2008

Completed
Last Updated

December 16, 2013

Status Verified

May 1, 2012

Enrollment Period

10 months

First QC Date

March 28, 2007

Last Update Submit

December 13, 2013

Conditions

Allergies

Keywords

PediatricAllergiesAntihistaminesNon-interventional

Outcome Measures

Primary Outcomes (1)

  • Parent satisfaction on a 11-point scale

    duration of the study

Secondary Outcomes (2)

  • Physician satisfaction on an 11-point scale

    duration of the study

  • Efficacy, tolerability and global satisfaction

    duration of the study

Eligibility Criteria

Age2 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Primary Care

You may qualify if:

  • Children from 2-12 included
  • History of allergy
  • Used an Antihistamine within market authorization

You may not qualify if:

  • Child not yet treated for the presented allergy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCB Pharma

Smyrna, Georgia, United States

Location

MeSH Terms

Conditions

Hypersensitivity

Condition Hierarchy (Ancestors)

Immune System Diseases

Study Officials

  • UCB Clinical Trial Call Center

    +1 877 822 9493 (UCB)

    STUDY DIRECTOR

Study Design

Study Type
observational
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 28, 2007

First Posted

March 29, 2007

Study Start

March 1, 2007

Primary Completion

January 1, 2008

Study Completion

January 1, 2008

Last Updated

December 16, 2013

Record last verified: 2012-05

Locations

US(1)